US EditionPublished • loading... • Updated
Ozempic Patent Expires: Generic Semaglutide Will Cheapen Treatments
Summary by Quintana Roo Hoy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Writing/Canton Group The expiry of the Ozempic patent in India will allow the production of generic semaglutide, reducing costs and expanding treatments against diabetes and obesity globally.The United States.- The expiry of the Ozempic patent in India marks a turning point in access to treatments against [...] The post Expires Ozempic patent: generics of semaglutide will cheapen treatments appeared first on Quintana Roo Today.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
